Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/137665
Share/Export:
logo share SHARE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Title

Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients

AuthorsDessa Sadovnick, A.; Alcina, Antonio; Fedetz, María; Matesanz, F.; Vilariño-Güell, Carles; Dessa Sadovnick, A.
Issue Date7-Jul-2016
PublisherGenetics Society of America
CitationG3 genes - genomes - genetics
AbstractMultiple sclerosis (MS) is a prevalent neurological disease of complex etiology. Here, we describe the characterization of a multi-incident MS family that nominated a rare missense variant (p.G420D) in plasminogen (PLG) as a putative genetic risk factor for MS. Genotyping of PLG p.G420D (rs139071351) in 2160 MS patients, and 886 controls from Canada, identified 10 additional probands, two sporadic patients and one control with the variant. Segregation in families harboring the rs139071351 variant, identified p.G420D in 26 out of 30 family members diagnosed with MS, 14 unaffected parents, and 12 out of 30 family members not diagnosed with disease. Despite considerably reduced penetrance, linkage analysis supports cosegregation of PLG p.G420D and disease. Genotyping of PLG p.G420D in 14446 patients, and 8797 controls from Canada, France, Spain, Germany, Belgium, and Austria failed to identify significant association with disease (P = 0.117), despite an overall higher prevalence in patients (OR = 1.32; 95% CI = 0.93–1.87). To assess whether additional rare variants have an effect on MS risk, we sequenced PLG in 293 probands, and genotyped all rare variants in cases and controls. This analysis identified nine rare missense variants, and although three of them were exclusively observed in MS patients, segregation does not support pathogenicity. PLG is a plausible biological candidate for MS owing to its involvement in immune system response, blood-brain barrier permeability, and myelin degradation. Moreover, components of its activation cascade have been shown to present increased activity or expression in MS patients compared to controls; further studies are needed to clarify whether PLG is involved in MS susceptibility.
DescriptionDessa Sadovnick, A.; Alcina, Antonio; Fedetz, María; Matesanz, F.; Vilariño-Güell, Carles; Dessa Sadovnick, A. et. al.
Publisher version (URL)http://www.g3journal.org/content/6/7/2073.long
URIhttp://hdl.handle.net/10261/137665
ISSN2160-1836
E-ISSN2160-1836
Appears in Collections:(IPBLN) Artículos

Files in This Item:
File Description SizeFormat
2073.full.pdf1,02 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work

PubMed Central
Citations

4
checked on May 8, 2022

SCOPUSTM   
Citations

8
checked on May 12, 2022

WEB OF SCIENCETM
Citations

7
checked on May 12, 2022

Page view(s)

221
checked on May 15, 2022

Download(s)

354
checked on May 15, 2022

Google ScholarTM

Check

Dimensions



WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.